Library

Moclobemide

A reversible MAOI which is prescribed to treat depression and anxiety. Its reversibility and short-acting length of effects often means it is used in "pharmahuasca" preparations.

Moclobemide molecular structure
Moclobemide molecular structure diagram from the DrugsPRO substance library.

Also known as: Aurorix, Manerix, Aurorex, Ro 11-1163

Classification

  • Chemical: Medicine
  • Tag: Pharmaceutical

Effects

  • Stimulation
  • Physical Energy
  • Insomnia
  • Nausea
  • Euphoria
  • Anxiety Suppression
  • Dizziness
  • Anxiety
  • Agitation

Routes of Administration

Oral

Dosage

  • Common: 300–600 mg/day (divided)
  • Light: 150–300 mg
  • Strong: 600–900 mg/day (divided)
  • Heavy: ≥900 mg/day (divided)
  • Threshold: 50 mg

Duration

  • Onset: 0.5-1.5 h
  • Peak: 1-4 h
  • Offset: 8-16 h
  • After Effects: 16-24 h
  • Total Duration: 8-16 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

Moclobemide - Guida alle sostanze DrugsPRO

Moclobemide: A reversible MAOI which is prescribed to treat depression and anxiety. Its reversibility and short-acting length of effects often means it is used in "pharmahuasca" preparations.

Related pages